Health Providers, Inc. (HPI) was the nation’s leading provider of “traveling” physical therapists, occupational therapists and speech pathologists to long-term care, rehabilitation, and acute care providers.
To capitalize on industry consolidation in the midst of a continuing shortage of therapists, HPI sought a strategic buyer to unlock shareholder value.
HPI was sold to ReLife, Inc. (NASD:RELF), a leading provider of rehabilitation services to patients throughout the eastern U.S. A principal of Carter Morse & Mathias served as HPI’s exclusive financial advisor in the transaction.
Carter Morse & Mathias is pleased to announce that Communication Networks, LLC ("ComNet") has been acquired by Access Control Related Enterprises, LLC ("ACRE"), a portfolio company of the private equity firm LLR Partners. CMM acted as the exclusive financial advisor to ComNet for this transaction.
Carter Morse & Mathias ("CMM") is pleased to announce that Excent Corporation, a provider of data management software solutions designed for special education and student intervention management, has been acquired by Frontline Education, the nation’s leading education software company backed by Insight Venture Partners ("Frontline").
The M&A Advisor is pleased to announce finalists of the 15th Annual M&A Advisor Awards. The Acquisition of Really Good Stuff by Excelligence, backed by Brentwood Associates was named a finalist in the Consumer Discretionary, Corporate & Strategic Acquisition & M&A Deal of the Year categories.
Securities are offered through Carter Capital Corporation, memberFINRA and SIPC.
This information should not be construed as a recommendation, offer to sell, or solicitation of an offer to buy a particular security or investment strategy. The commentary provided is for informational purposes only and should not be relied on for accounting, legal, tax or other professional advice. While the information herein is deemed reliable, CMM cannot guarantee its accuracy, completeness, or suitability for any purpose, and makes no warranties with regard to the results to be obtained from its use.